Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Interim 75 patients Data might be good (Dec 14th Week)
View:
Post by Biofinanace on Dec 06, 2020 7:06pm

Interim 75 patients Data might be good (Dec 14th Week)

Based on the evidence generated by 2 independent groups speaks in favor of the positive outcomes - 

1) https://msystems.asm.org/content/msys/4/6/e00431-19.full.pdf - 
This was pub in 2019 Dec just when COVID was being detected for the first time. The Chinese group clearly showed a positive impact of Ifenprodil on H5N1-induced-Acute lung injury mouse model through alleviation of H5N1-induced cytokine storm in mouse lungs (Fig 3, Ifenprodil dubbed No.42)

2) https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7263237&blobtype=pdf
This was pub in 2020 May by University of Texas group. These findings reveal a potential new pathway for sensory modulation of lung pathophysiology involving glutamate from sensory afferents acting on NMDA receptors expressed by resident cells in the lung. 

This data will break or make Algernon. I would have been more excited to see Ifenprodil patient activity in Cough/IPF rather in COVID indication, but this will be the first time AGN would showcase Ifenprodil relevance. Any positive outcome might shoot up this company to $1 zone. And this will help AGN to raise $10-15M for successfuly running/finishing Ifenprodil  relevancy in Cough/IPF. 

Fingers Crossed !
Comment by TruthBeTold7 on Dec 07, 2020 12:26am
This post has been removed in accordance with Community Policy
Comment by Danorrn on Dec 07, 2020 5:41am
Go into your local ER and breath deeply. Then visit everyone you love over the next week or so you f'ing moron.
Comment by Danorrn on Dec 07, 2020 5:57am
To the qanon covidiot...I deal with this virus everyday. The virus also causes severe clotting. You do understand that we have blood vessels throughout our bodies? This means many organs including the heart and brain are at risk. You're so paranoid of the news media you're willing to follow any other news regardless of it being science based or not. The virus and its effects are real.
Comment by Danorrn on Dec 07, 2020 6:04am
Sorry eveyone, one last angry point... to the covidiot...when you can't breathe, you can't get enough oxygen. When you can't get enough oxygen, you can die from a heart attack and many other unpleasant injuries.
Comment by Laliberte2020 on Dec 07, 2020 7:08am
Don't bother answering them, they probably don't even read back. Anyways they are brainwashed, it's like arguing with the Jehovah witness knocking on your door.